Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage

Citations Over TimeTop 1% of 2016 papers

Abstract

Hotspot mutations in the spliceosome gene SF3B1 are reported in ∼20% of uveal melanomas. SF3B1 is involved in 3'-splice site (3'ss) recognition during RNA splicing; however, the molecular mechanisms of its mutation have remained unclear. Here we show, using RNA-Seq analyses of uveal melanoma, that the SF3B1(R625/K666) mutation results in deregulated splicing at a subset of junctions, mostly by the use of alternative 3'ss. Modelling the differential junctions in SF3B1(WT) and SF3B1(R625/K666) cell lines demonstrates that the deregulated splice pattern strictly depends on SF3B1 status and on the 3'ss-sequence context. SF3B1(WT) knockdown or overexpression do not reproduce the SF3B1(R625/K666) splice pattern, qualifying SF3B1(R625/K666) as change-of-function mutants. Mutagenesis of predicted branchpoints reveals that the SF3B1(R625/K666)-promoted splice pattern is a direct result of alternative branchpoint usage. Altogether, this study provides a better understanding of the mechanisms underlying splicing alterations induced by mutant SF3B1 in cancer, and reveals a role for alternative branchpoints in disease.

Related Papers

• → METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL(2023)27 cited
• → Human step II splicing factor hSlu7 functions in restructuring the spliceosome between the catalytic steps of splicing(1999)55 cited
• → SAP30BP interacts with RBM17/SPF45 to promote splicing in a subset of human short introns(2022)
• → Abstract 3482: METTL3-mediated m6A modification controls splicing factor abundance and contributes to CLL progression(2023)
• → Supplementary Figures S1-8 from METTL3-Mediated m<sup>6</sup>A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL(2023)